pd 98059 has been researched along with sulindac sulfide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinicrope, FA; Sun, Y | 1 |
| Kim, CH; Kim, JY; Kim, KS; Lee, BJ; Lee, JG; Song, KS; Yoon, JH | 1 |
| Akella, R; Goldsmith, EJ; Moon, TM | 1 |
| Baek, SJ; Eling, TE; Kambe, A; Kamitani, H; Watanabe, T; Yoshioka, H | 1 |
1 review(s) available for pd 98059 and sulindac sulfide
| Article | Year |
|---|---|
Unique MAP Kinase binding sites.
Topics: Amino Acid Motifs; Animals; Antineoplastic Agents; Binding Sites; Crystallography, X-Ray; Flavonoids; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Sulindac | 2008 |
3 other study(ies) available for pd 98059 and sulindac sulfide
| Article | Year |
|---|---|
Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase Inhibitors; Drug Synergism; Enzyme Inhibitors; Flavonoids; Humans; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Sulfonamides; Sulindac | 2005 |
Sulindac sulfide-induced apoptosis in sinonasal cancer cells.
Topics: Amino Acid Chloromethyl Ketones; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carcinoma, Squamous Cell; Caspase Inhibitors; Flavonoids; Fluorescence; Humans; Imidazoles; Mitogen-Activated Protein Kinases; Paranasal Sinus Neoplasms; Pyridines; Signal Transduction; Sulindac | 2005 |
The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.
Topics: Activating Transcription Factor 3; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Brain Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Chromatin Immunoprecipitation; Colony-Forming Units Assay; Cyclooxygenase Inhibitors; Early Growth Response Protein 1; Flavonoids; Glioblastoma; Humans; Immunoprecipitation; Luciferases; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Promoter Regions, Genetic; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sp1 Transcription Factor; Sulindac; Tumor Cells, Cultured | 2009 |